Sort by
Items per page

Send to

Choose Destination

See Gene information for adam12 egfr

adam12 in Homo sapiens (2)Mus musculus (2)Rattus norvegicus (2)All 245 Gene records

egfr in Homo sapiens (2)Mus musculus (2)Rattus norvegicus (2)All 268 Gene records

Search results

Items: 1 to 20 of 28


Triptolide inhibits pituitary adenoma cell viability, migration and invasion via ADAM12/EGFR signaling pathway.

Wang J, Zhang Z, Li R, Sun W, Chen J, Zhang H, Shu K, Lei T.

Life Sci. 2018 Feb 1;194:150-156. doi: 10.1016/j.lfs.2017.12.037. Epub 2017 Dec 27.


Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.

Inoue Y, Shimazawa M, Nakamura S, Takata S, Hashimoto Y, Izawa H, Masuda T, Tsuruma K, Sakaue T, Nakayama H, Higashiyama S, Hara H.

Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):174-185. doi: 10.1161/ATVBAHA.117.310337. Epub 2017 Nov 30.


ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.

Wang J, Zhang Z, Li R, Mao F, Sun W, Chen J, Zhang H, Bartsch JW, Shu K, Lei T.

Biomed Pharmacother. 2018 Jan;97:1066-1077. doi: 10.1016/j.biopha.2017.11.034. Epub 2017 Nov 9.


ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.

Roy R, Dagher A, Butterfield C, Moses MA.

Mol Cancer Res. 2017 Nov;15(11):1608-1622. doi: 10.1158/1541-7786.MCR-17-0188. Epub 2017 Aug 1.


Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.

Duhachek-Muggy S, Qi Y, Wise R, Alyahya L, Li H, Hodge J, Zolkiewska A.

Mol Cancer. 2017 Feb 1;16(1):32. doi: 10.1186/s12943-017-0599-6.


ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.

Ma B, Ma Q, Jin C, Wang X, Zhang G, Zhang H, Seeger H, Mueck AO.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):13279-83. eCollection 2015.


Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain.

Miller MA, Moss ML, Powell G, Petrovich R, Edwards L, Meyer AS, Griffith LG, Lauffenburger DA.

Sci Rep. 2015 Oct 19;5:15150. doi: 10.1038/srep15150.


Erbb2 up-regulation of ADAM12 expression accelerates skin cancer progression.

Rao VH, Vogel K, Yanagida JK, Marwaha N, Kandel A, Trempus C, Repertinger SK, Hansen LA.

Mol Carcinog. 2015 Oct;54(10):1026-36. doi: 10.1002/mc.22171. Epub 2014 May 5.


A substrate-optimized electrophoretic mobility shift assay for ADAM12.

Kotzsch A, Skovgaard T, Buus U, Andersen S, Devkota K, Berthelsen J.

Anal Biochem. 2014 May 1;452:34-42. doi: 10.1016/j.ab.2014.02.008. Epub 2014 Feb 15.


Notch increases the shedding of HB-EGF by ADAM12 to potentiate invadopodia formation in hypoxia.

Díaz B, Yuen A, Iizuka S, Higashiyama S, Courtneidge SA.

J Cell Biol. 2013 Apr 15;201(2):279-92. doi: 10.1083/jcb.201209151.


An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer.

Li H, Duhachek-Muggy S, Qi Y, Hong Y, Behbod F, Zolkiewska A.

Breast Cancer Res Treat. 2012 Oct;135(3):759-69. doi: 10.1007/s10549-012-2220-4. Epub 2012 Aug 29.


Constitutive coupling of a naturally occurring human alpha1a-adrenergic receptor genetic variant to EGFR transactivation pathway.

Oganesian A, Yarov-Yarovoy V, Parks WC, Schwinn DA.

Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19796-801. doi: 10.1073/pnas.1116271108. Epub 2011 Nov 16.


A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion.

Rao VH, Kandel A, Lynch D, Pena Z, Marwaha N, Deng C, Watson P, Hansen LA.

Oncogene. 2012 Jun 7;31(23):2888-98. doi: 10.1038/onc.2011.460. Epub 2011 Oct 10.


The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?

Duffy MJ, Mullooly M, O'Donovan N, Sukor S, Crown J, Pierce A, McGowan PM.

Clin Proteomics. 2011 Jun 9;8(1):9. doi: 10.1186/1559-0275-8-9.


ADAM12 induces estrogen-independence in breast cancer cells.

Roy R, Moses MA.

Breast Cancer Res Treat. 2012 Feb;131(3):731-41. doi: 10.1007/s10549-011-1431-4. Epub 2011 Mar 9.


Role of A disintegrin and metalloprotease-12 in neutrophil recruitment induced by airway epithelium.

Estrella C, Rocks N, Paulissen G, Quesada-Calvo F, Noël A, Vilain E, Lassalle P, Tillie-Leblond I, Cataldo D, Gosset P.

Am J Respir Cell Mol Biol. 2009 Oct;41(4):449-58. doi: 10.1165/rcmb.2008-0124OC. Epub 2009 Feb 12.


The metalloproteinase ADAM-12 regulates bronchial epithelial cell proliferation and apoptosis.

Rocks N, Estrella C, Paulissen G, Quesada-Calvo F, Gilles C, Guéders MM, Crahay C, Foidart JM, Gosset P, Noel A, Cataldo DD.

Cell Prolif. 2008 Dec;41(6):988-1001. doi: 10.1111/j.1365-2184.2008.00557.x.


Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer.

Shimura T, Kataoka H, Ogasawara N, Kubota E, Sasaki M, Tanida S, Joh T.

Clin Cancer Res. 2008 Jun 15;14(12):3956-65. doi: 10.1158/1078-0432.CCR-07-4794.


Fibroblast growth factor induces a neural stem cell phenotype in foetal forebrain progenitors and during embryonic stem cell differentiation.

Pollard SM, Wallbank R, Tomlinson S, Grotewold L, Smith A.

Mol Cell Neurosci. 2008 Jul;38(3):393-403. doi: 10.1016/j.mcn.2008.03.012. Epub 2008 Apr 10.


Supplemental Content

Loading ...
Support Center